Recombinant Squalus acanthias LDHA is a genetically engineered form of the lactate dehydrogenase A enzyme derived from the spiny dogfish shark. It catalyzes the reversible conversion of pyruvate to lactate using NADH as a cofactor, playing a central role in anaerobic respiration . This enzyme is structurally homologous to human LDHA (79.9% sequence identity), making it a valuable model for studying mammalian lactate dehydrogenase mechanisms and inhibitors .
The enzyme is produced using multiple recombinant platforms to ensure functional fidelity and high yield:
These systems enable large-scale production for biochemical assays, structural studies, and therapeutic research .
Catalytic Activity: Recombinant Squalus acanthias LDHA demonstrates comparable or higher specific activity than endogenous human LDH5 in pyruvate-to-lactate conversion assays .
pH Sensitivity: Structural stability varies with pH; citrate replaces sulfate ions at pH 6.0, altering anion binding without disrupting catalysis .
Thermodynamic Flexibility: B-factor analysis highlights increased mobility in the N-terminal and active-site loops, suggesting conformational adaptability during substrate binding .
LDHA is overexpressed in tumors to sustain the Warburg effect (aerobic glycolysis). Recombinant Squalus acanthias LDHA serves as:
A drug discovery target for small-molecule inhibitors to disrupt cancer metabolism .
A comparative model for evaluating species-specific differences in LDHA inhibition .
A tool for functional studies of mutations linked to pathologies like exertional myoglobinuria .
The enzyme’s structural resolution (e.g., PDB 6LDH) has advanced understanding of:
Future studies may leverage its recombinant form to design isoform-specific inhibitors or engineer thermostable variants for industrial applications .
The catalytic activity of Squalus acanthias L-LDHA is defined by its conserved active site architecture, which includes critical residues such as His195, Arg171, and Asp168. These residues coordinate substrate binding and proton transfer during the interconversion of pyruvate and lactate . Structural refinements at 2.0 Å resolution revealed a sulfate ion bound near His195, forming hydrogen bonds with Asn140 and Asp168 . This sulfate occupies the putative pyruvate-binding site, mimicking the substrate’s carboxyl group. Researchers analyzing catalytic mechanisms should prioritize mutagenesis of these residues and employ competitive inhibition assays using sulfate analogs.
| Parameter | Value | Implications |
|---|---|---|
| Resolution | 2.0 Å | Enables atomic-level residue mapping |
| R-factor | 0.202 | High model accuracy |
| Coordinating residues | His195, Arg171, Asp168 | Critical for substrate binding |
| Bound ions per subunit | 2 sulfate ions | Mimic substrate interactions |
Discrepancies in L-LDHA structural data often arise from pH-dependent ligand binding or sequence misassignments. For example, the original sequence (WNALKE, residues 207–211) in Squalus acanthias L-LDHA was revised to NVASIK after electron density analysis . To address such issues:
Validate sequence alignment using de novo sequencing or cryo-EM density maps.
Compare multiple datasets collected under varying conditions (e.g., pH 6.0 vs. 7.8) to assess ligand occupancy .
Utilize restrained least-squares refinement to minimize model bias, especially for flexible loops (residues 97–123) .
The heterologous expression of Squalus acanthias L-LDHA in Escherichia coli requires codon optimization and stringent purification protocols. Key steps include:
Vector design: Use pET or pGEX systems with inducible promoters (e.g., T7 or lacUV5).
Codon optimization: Replace rare codons in the LDHA gene to match E. coli tRNA abundance.
Affinity purification: Employ His-tag or GST-tag systems, followed by size-exclusion chromatography to remove aggregates .
Activity validation: Perform coupled assays with NADH and pyruvate, monitoring absorbance at 340 nm .
Lysine acetylation is a critical PTM that inhibits L-LDHA activity by disrupting substrate binding. In Streptococcus mutans, acetylation by ActA reduces lactic acid production by 40–60% . To study PTMs:
Overexpress acetyltransferases (e.g., ActA) in host systems and monitor acetylation via anti-acetyllysine immunoblotting .
Map acetylation sites using LC-MS/MS after tryptic digestion. Ten acetylation sites were identified in S. mutans LDH, seven of which are conserved in vertebrates .
Correlate PTMs with activity: Use enzymatic assays under varying acetylation states (e.g., ±Ac-CoA) .
| Acetylation Site | Conservation (%) | Activity Reduction (%) |
|---|---|---|
| Lys12 | 85 | 22 ± 3.1 |
| Lys78 | 92 | 34 ± 2.8 |
| Lys156 | 76 | 41 ± 4.2 |
Comparative studies in hypoxia-tolerant organisms, such as Macrobrachium nipponense, reveal LDH’s regulation by hypoxia-inducible factor 1 (HIF-1). Methodologies include:
Promoter analysis: Clone the LDHA promoter upstream of luciferase and quantify hypoxia-induced expression .
RNA interference: Knock down HIF-1α/β subunits and measure LDHA mRNA/protein levels via qRT-PCR and Western blotting .
Enzymatic profiling: Compare lactate production in normoxic vs. hypoxic conditions using spectrophotometric assays .
Discrepancies in kinetic parameters (e.g., K<sub>m</sub> for pyruvate) often stem from assay conditions. Standardize protocols by:
Buffering systems: Use 50 mM Tris-HCl (pH 7.5) to avoid pH fluctuations during assays .
Cofactor concentrations: Maintain NADH at 0.2–0.4 mM to prevent substrate inhibition .
Temperature control: Conduct assays at 25°C for comparability with crystallographic data .
Protein stability is enhanced by:
Ligand stabilization: Incubate with 10 mM oxamate or sulfate to stabilize the active site .
Avoid freeze-thaw cycles: Aliquot purified protein into single-use volumes.
The “flexible loop” (residues 97–123) undergoes substrate-induced closure, positioning Arg105 and Gln102 for hydrogen bonding with pyruvate . To study flexibility: